{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T22:57:38Z","timestamp":1776293858787,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ashley Martucci Fund for FOP Research"},{"DOI":"10.13039\/100013117","name":"International Fibrodysplasia Ossificans Progressiva Association","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013117","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Center for Research in FOP and Related Disorders"},{"name":"Ian Cali Endowment for FOP Research"},{"DOI":"10.13039\/100013182","name":"Whitney Weldon Endowment for FOP Research","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013182","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Isaac and Rose Nassau Professorship of Orthopaedic Molecular Medicine"},{"DOI":"10.13039\/100006920","name":"University of Pennsylvania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Radiant Hope Foundation"}],"content-domain":{"domain":["clinicalkey.jp","thebonejournal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.bone.2017.12.024","type":"journal-article","created":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T18:30:53Z","timestamp":1514399453000},"page":"201-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells"],"prefix":"10.1016","volume":"109","author":[{"given":"Haitao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Behrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J.","family":"Pignolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick S.","family":"Kaplan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"S-2","key":"10.1016\/j.bone.2017.12.024_bb0005","first-page":"437","article-title":"Fibrodysplasia ossificans progressiva: diagnosis management, and therapeutic horizons","volume":"10","author":"Pignolo","year":"2013","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"10.1016\/j.bone.2017.12.024_bb0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.2728","article-title":"The natural history of flare-ups in fibrodysplasia ossificans progressiva: a comprehensive global assessment","volume":"31","author":"Pignolo","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ng1783","article-title":"A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva","volume":"38","author":"Shore","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2017.12.024_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/humu.20868","article-title":"Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1","volume":"30","author":"Kaplan","year":"2009","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bone.2017.12.024_bb0025","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cytogfr.2009.10.006","article-title":"The FOP metamorphogene encodes a novel type I receptor that dysregulates BMP signaling","volume":"20","author":"Kaplan","year":"2009","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.bone.2017.12.024_bb0030","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11914-015-0258-z","article-title":"The immunological contribution to heterotopic ossification disorders","volume":"13","author":"Convente","year":"2015","journal-title":"Curr. Osteoporos. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0035","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.semcdb.2015.12.013","article-title":"Granting immunity to FOP and catching heterotopic ossification in the Act","volume":"49","author":"Kaplan","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bone.2017.12.024_bb0040","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1359\/jbmr.071030","article-title":"Dysregulated BMP signaling and enhanced osteogenic differentiation of connective tissue progenitor cells from patients with fibrodysplasia ossificans progressiva","volume":"23","author":"Billings","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bone.2017.12.024_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2012.00182","article-title":"Toll-like receptors as modulators of mesenchymal stem cells","author":"DelaRosa","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bone.2017.12.024_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/315941","article-title":"Danger signals activating the immune response after trauma","author":"Hirsiger","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.bone.2017.12.024_bb0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.humimm.2009.12.005","article-title":"Inflammation modifies the pattern and function of Toll-like receptors expressed by human mesenchymal stromal cells","volume":"71","author":"Raicevic","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.bone.2017.12.024_bb0065","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1101\/gad.1145603","article-title":"ECSIT is required for Bmp signaling and mesoderm formation during mouse embryogenesis","volume":"17","author":"Xiao","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2017.12.024_bb0070","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1101\/gad.1161403","article-title":"Ecsit-ement on the crossroads of Toll and BMP signal transduction","volume":"17","author":"Moustakas","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2017.12.024_bb0075","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jbmr.2848","article-title":"Cellular hypoxia promotes heterotopic ossification by amplifying BMP signaling","volume":"31","author":"Wang","year":"2016","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0080","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1158\/0008-5472.CAN-13-2845","article-title":"Optimal effector functions in human natural killer cells rely upon autocrine bone morphogenetic protein signaling","volume":"74","author":"Robson","year":"2014","journal-title":"Cancer Res."},{"issue":"303","key":"10.1016\/j.bone.2017.12.024_bb0085","doi-asserted-by":"crossref","first-page":"303ra137","DOI":"10.1126\/scitranslmed.aac4358","article-title":"ACVR1R206H receptor mutation causes fibrodysplasia ossificans progressiva by imparting responsiveness to activin A","volume":"7","author":"Hatsell","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.bone.2017.12.024_bb0090","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1510540112","article-title":"Neofunction of ACVR1 in fibrodysplasia ossificans progressiva","author":"Hino","year":"2015","journal-title":"PNAS"},{"key":"10.1016\/j.bone.2017.12.024_bb0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bone.2017.12.024_bb0100","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jbmr.1562","article-title":"Multipotent progenitors resident in the skeletal muscle interstitium exhibit robust BMP-dependent osteogenic activity and mediate heterotopic ossification","volume":"27","author":"Wosczyna","year":"2012","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.cell.2013.02.053","article-title":"Type 2 innate signals stimulate fibro\/adipogenic progenitors to facilitate muscle regeneration","volume":"153","author":"Heredia","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.12.024_bb0110","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature09973","article-title":"TLR signaling augments macrophage bactericidal activity through mitochondrial ROS","volume":"472","author":"West","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bone.2017.12.024_bb0115","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1101\/gad.13.16.2059","article-title":"ECSIT is an evolutionarily conserved intermediate in the Toll\/IL-1 signal transduction pathway","volume":"13","author":"Kopp","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.bone.2017.12.024_bb0120","doi-asserted-by":"crossref","first-page":"35205","DOI":"10.1074\/jbc.M114.597187","article-title":"TAK1-ECSIT-TRAF6 complex plays a key role in the TLR4 signal to activate NF-\u03baB","volume":"289","author":"Wi","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2017.12.024_bb0125","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000365971","article-title":"ECSIT bridges RIG-I-like receptors to VISA in signaling events of innate antiviral responses","volume":"7","author":"Lei","year":"2015","journal-title":"J. Innate Immun."},{"key":"10.1016\/j.bone.2017.12.024_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/mus.21959","article-title":"Role for Toll-like receptor 3 in muscle regeneration after cardiotoxin injury","volume":"43","author":"Mathes","year":"2011","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bone.2017.12.024_bb0135","article-title":"Expression of toll-like receptors by human muscle cells in vitro and in vivo: TLR3 is highly expressed in inflammatory and HIV myopathies, mediates IL-8 release, and up-regulation ofNKG2D-ligands","author":"Schreiner","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.bone.2017.12.024_bb0140","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1165\/rcmb.2008-0371OC","article-title":"Activation of Toll-like receptor 3 augments myofibroblast differentiation","volume":"40","author":"Sugiura","year":"2009","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.bone.2017.12.024_bb0145","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1002\/art.27465","article-title":"Expression of Toll-like receptor 3 and Toll-like receptor 7 in muscle is characteristic of inflammatory myopathy and is differentially regulated by Th1 and TH17 cytokines","volume":"62","author":"Tournadre","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2017.12.024_bb0150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/annrheumdis-2012-202207","article-title":"TLR4 as a receptor for HMGB1 induced muscle dysfunction in myositis","volume":"72","author":"Zong","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bone.2017.12.024_bb0155","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1128\/CMR.00022-07","article-title":"Sensing viral infection and activation of innate immunity by Toll-like receptor 3","volume":"21","author":"Vercammen","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.bone.2017.12.024_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4161\/sgtp.2.2.15378","article-title":"Regulation of Toll and Toll-like receptor signaling by the endocytic pathway","volume":"2","author":"Lund","year":"2011","journal-title":"Small GTPases"},{"key":"10.1016\/j.bone.2017.12.024_bb0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cell.2012.09.034","article-title":"Activation of innate immunity is required for efficient nuclear reprogramming","volume":"151","author":"Lee","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.bone.2017.12.024_bb0170","article-title":"Mast cell inhibition as a therapeutic approach in fibrodysplasia ossificans progressiva","author":"Brennan","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.bone.2017.12.024_bb0175","article-title":"Depletion of Mast cells and macrophages impairs heterotopic ossification in an ACVR1 (R206H) mouse model of fibrodysplasia ossificans progressiva","author":"Convente","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2017.12.024_bb0180","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2106\/JBJS.F.00472","article-title":"Hematopoietic stem-cell contribution to ectopic skeletogenesis","volume":"89","author":"Kaplan","year":"2007","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.bone.2017.12.024_bb0185","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1080\/21678707.2017.1304211","article-title":"Hard targets for a second skeleton: therapeutic horizons for fibrodysplasia ossificans progressiva (FOP)","volume":"5","author":"Kaplan","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.bone.2017.12.024_bb0190","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrd3203","article-title":"Targeting Toll-like receptors: emerging therapeutics?","volume":"9","author":"Hennessy","year":"2010","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328217304842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T03:54:30Z","timestamp":1719719670000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328217304842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":38,"alternative-id":["S8756328217304842"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.024","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECSIT links TLR and BMP signaling in FOP connective tissue progenitor cells","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2017.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}